Press brief by Arjun Vasant Balar, MD of the NYU Langone Medical Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Atezolizumab as 1L therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma mUC: IMvigor210 cohort 1
